Low-dose STZ can slightly damage the function of pancreatic β cells and can moderately reduce insulin secretion, creating symptoms similar to those in patients with type 2 diabetes insulin hyposecretion(20). The gene discussed is INS; the disease is type 2 diabetes mellitus.